Gandhi Viral, Hewston Matthew, Yadam Suman, Ma Kiet, Singh Anil C, Cheema Tariq
Division of Pulmonary and Critical Care Medicine (Drs Gandhi, Yadam, Ma, Singh, and Cheema) and Department of Medicine (Dr Hewston), Allegheny General Hospital, Pittsburgh, Pennsylvania; and Temple University School of Medicine, University in Philadelphia, Pennsylvania (Drs Singh and Cheema).
Crit Care Nurs Q. 2017 Jul/Sep;40(3):260-275. doi: 10.1097/CNQ.0000000000000164.
Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. They pose a significant risk for morbidity and mortality. In an appropriate clinical setting, invasive interventions, including administration of thrombolytics, anticoagulation, and placement of vena cava filter, are warranted. Bleeding, postthrombotic syndrome, recurrence, and filter-associated complications are few of the complications of this disease. More recently, chronic thromboembolic pulmonary hypertension has gained clinical interest in patients with pulmonary embolism and has warranted close follow-up.
静脉血栓栓塞包括深静脉血栓形成和肺栓塞。它们对发病率和死亡率构成重大风险。在适当的临床情况下，有必要进行侵入性干预，包括给予溶栓剂、抗凝治疗以及放置腔静脉滤器。出血、血栓形成后综合征、复发以及滤器相关并发症是该疾病的部分并发症。最近，慢性血栓栓塞性肺动脉高压在肺栓塞患者中引起了临床关注，需要密切随访。
